4//SEC Filing
ALLOS THERAPEUTICS INC 4
Accession 0001127602-12-008162
CIK 0001097264operating
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 5:43 PM ET
Size
6.5 KB
Accession
0001127602-12-008162
Insider Transaction Report
Form 4
BENNETT BRUCE K JR
VP, Manufacturing
Transactions
- Sale
Common Stock
2012-02-23$1.58/sh−4,484$7,085→ 111,041 total - Sale
Common Stock
2012-02-24$1.55/sh−1,469$2,277→ 109,572 total
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a 10b5-1 plan under which Mr. Bennett sold a portion of his holdings for tax and estate planning purposes.
- [F2]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $1.5800 to $1.5801. Upon request of the SEC staff, Allos Therapeutics, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.
Documents
Issuer
ALLOS THERAPEUTICS INC
CIK 0001097264
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001097264
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 5:43 PM ET
- Size
- 6.5 KB